Eton Pharmaceuticals, Inc. ETON

ETON Company Overview

Eton Pharmaceuticals, Inc. is a U.S.-based specialty pharmaceutical company focused on developing, acquiring, and commercializing treatments for rare diseases and other underserved medical conditions. The company primarily operates in the pharmaceutical and biotechnology industries, with an emphasis on hospital products, endocrinology therapies, and pediatric-focused medicines. Eton’s business model combines internal product development with the acquisition or licensing of niche pharmaceutical assets that address limited-competition markets and unmet clinical needs.

The company’s primary revenue drivers are prescription pharmaceutical products marketed in the United States, including therapies for endocrine disorders, rare metabolic diseases, and hospital-administered treatments. Eton has differentiated itself through a strategy centered on reformulations, orphan-drug opportunities, and commercialization of products with relatively small but specialized patient populations. Founded in 2017 and headquartered in Illinois, the company evolved from an early-stage specialty pharma platform into a commercial-stage business through a combination of FDA approvals, strategic licensing agreements, and targeted acquisitions of niche assets.